[Effect of BCNU on glutathione metabolism in human blood cells].

Abstract

BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) at therapeutical doses inhibits almost completely glutathione reductase of the patients' red cells and paltelets. Red cell glutathione reduction is diminished simultaneously. These changes are fully reversible in red cells and platelets derived in the following days after application of BCNU. Clinical signs of red… (More)

Topics

  • Presentations referencing similar topics